Hims & Hers Health (HIMS) Interest Expenses (2020 - 2026)
Hims & Hers Health (HIMS) posted Interest Expenses of $19.4 million for Q1 2026, up 609.84% sequentially from -$3.8 million in Q4 2025, and up 553.86% YoY from $3.0 million in Q1 2025.
Hims & Hers Health (HIMS) Interest Expenses (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Interest Expenses for 7 years, with the latest figure at $19.4 million in Q1 2026.
- Quarterly Interest Expenses rose 553.86% year-over-year to $19.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.4 million (up 553.86% YoY) and the FY2025 annual result came in at $170.5 million, down 8.03% from the prior year.
- Interest Expenses grew to $19.4 million in Q1 2026 per HIMS's latest filing, from -$3.8 million in the prior quarter.
- Over five years, Interest Expenses peaked at $354.4 million in Q3 2025 and troughed at -$3.8 million in Q4 2025.
- A 5-year average of $74.4 million and a median of $19.4 million in 2026 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses jumped 4992.53% in 2022, then tumbled 445.45% in 2025.
- Over 5 years, Interest Expenses stood at $400000.0 in 2022, then jumped by 50.0% to $600000.0 in 2023, then surged by 83.33% to $1.1 million in 2024, then sank by 445.45% to -$3.8 million in 2025, then jumped by 609.84% to $19.4 million in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $19.4 million, -$3.8 million, and $354.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Hims & Hers Health | 7.51 Bn | 6.67 Bn | 480.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 258.59 Mn |
| Jun 30, 2026 | 258.59 Mn |
| Mar 31, 2026 | 19.37 Mn |
| Mar 31, 2026 | 19.37 Mn |
| Dec 31, 2025 | -3.80 Mn |
| Dec 31, 2025 | -3.80 Mn |
| Sep 30, 2025 | 354.41 Mn |
| Sep 30, 2025 | 354.41 Mn |
| Jun 30, 2025 | 345.81 Mn |
| Jun 30, 2025 | 345.81 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Sep 30, 2024 | 145.83 Mn |
| Sep 30, 2024 | 145.83 Mn |
| Jun 30, 2024 | 169.85 Mn |
| Jun 30, 2024 | 169.85 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Mar 31, 2024 | 2.35 Mn |